Premium
P2‐310: Exebryl‐1: A novel small‐molecule drug that markedly reduces amyloid plaque load and improves memory, enters human clinical trials
Author(s) -
Snow Alan D.,
Cummings Joel A.,
Lake Thomas P.,
Esposito Luke A.,
Hudson F. Michael,
Hu Qubai,
Cam Judy A.,
Aker Jocelyn R.,
Runnels Steve
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.1387
Subject(s) - amyloid (mycology) , thioflavin , congo red , pharmacology , genetically modified mouse , amyloid beta , pathology , immunostaining , medicine , alzheimer's disease , chemistry , transgene , biochemistry , immunohistochemistry , disease , organic chemistry , adsorption , gene